Get the app
US › Healthcare

Cytosorbents Crp (CTSO)

US · Healthcare · Medical Devices

$4.11+34.31%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$9.6M
Revenue YoY
+0.2%
Net profit
$-4.4M
Profit YoY
-326.9%
EPS
$-0.07
EPS estimate
$-0.05
Net margin
-45.9%

EPS came in at -0.07 against a street estimate of -0.05 — a miss of 40.0%.

Key statistics

Market cap
$10.9M
Forward P/E
7.2
P/B
11.43
Book value
$-0.24
EPS (TTM)
$-5.80
52-week high
$18.40
52-week low
$2.96
50-day MA
$6.07
200-day MA
$10.12
Beta
1.37

Analyst view

Analysts rate Cytosorbents Crp a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $47.50.

Shareholding

Insiders
16.25%
Institutions
25.53%

Largest institutional holders

FundStake
Avenir Corporation8.23%
Neuberger Berman Group LLC3.12%
Vanguard Capital Management, LLC3.04%
CM Management, LLC2.34%
Skylands Capital, LLC1.92%
BlackRock Inc1.00%
Geode Capital Management, LLC0.96%
Sargent Investment Group, LLC0.88%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cytosorbents Crp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.